• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 10 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 3 months ago by International Alliance.
      • This topic was modified 6 years, 3 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Rob Tison, USA

      Rob Tison, USA

    • Manuel Arn, Switzerland

      Manuel Arn, Switzerland

    • Soledad Rodriguez, Spain

      Soledad Rodriguez, Spain

    • Orlando Ruiz, Colombia

      Orlando Ruiz, Colombia

    • Steve Gallagher, Canada

      Steve Gallagher, Canada
      Picture1

    • Amparo Muriel Engativa, Colombia

      Amparo Muriel Engativa, Colombia

    • Ali Var, Turkey

      Ali Var, Turkey

    • Frank Taylor, USA

      Frank Taylor, USA

    • Danny Reviers, Belgium

      Danny Reviers, Belgium
      DannyReviers

    • Lineke Veenstra, Netherlands

      Lineke Veenstra, Netherlands

    • Mary Thomas, Australia

      Mary Thomas, Australia

    • Hollister

      Hollister
      hollister

    • Zabun Nassar, England

      Zabun Nassar, England

    • Shay Rishoni, Netherlands

      Shay Rishoni, Netherlands

    • Den Haag, Netherlands

      Den Haag, Netherlands

    • Hans Dieter Olszewski, Germany

      Hans Dieter Olszewski, Germany

    • Timmy, Belgium

      Timmy, Belgium

    • Mauril Belanger, Canada

      Mauril Belanger, Canada

    • Leon Ryba, Argentina

      Leon Ryba, Argentina

    • Brian Lovell, Australia

      Brian Lovell, Australia

    • David Solomon, UK

      David Solomon, UK

    • Lachlan Terry, Australia

      Lachlan Terry, Australia

    • Daniela Maria Daverio, Argentina

      Daniela Maria Daverio, Argentina

    • Phil Rossall, UK

      Phil Rossall, UK

    • Steven Gallagher, Canada

      Steven Gallagher, Canada

    • João Marcos Andrietta, Brazil

      João Marcos Andrietta, Brazil

    • Len Johnrose, England

      Len Johnrose, England

    • Jose Rivero Muñoz, Mexico

      Jose Rivero Muñoz, Mexico

    • Ann Nicol, USA

      Ann Nicol, USA

    • Vincent Bourque, Canada

      Vincent Bourque, Canada
      vincent_bourque

    • Rosie Riley, USA

      Rosie Riley, USA

    • Catherine Pearce, Australia

      Catherine Pearce, Australia

    • Philip Brindle, England

      Philip Brindle, England

    • Marco Antonio Alvarez Mercado, Mexico

      Marco Antonio Alvarez Mercado, Mexico

    • Dick Dayton, USA

      Dick Dayton, USA

    • Fabio Correia, Brazil

      Fabio Correia, Brazil

    • Christian Bär, Germany

      Christian Bär, Germany

    • Lin Yong Yi, Taiwan

      Lin Yong Yi, Taiwan

    • Daniel Hare, USA

      Daniel Hare, USA

    • Mike Rannie, Canada

      Mike Rannie, Canada

    • Frank Bos, Netherlands

      Frank Bos, Netherlands

    • Antonio Ventriglia, Belgium

      Antonio Ventriglia, Belgium

    • Wiebke Braach, Germany

      Wiebke Braach, Germany

    • Xian-Zhang Niu, China

      Xian-Zhang Niu, China

    • Mikey Stone, ALS

      Mikey Stone, ALS

    • Francisco Perez Palop, Spain

      Francisco Perez Palop, Spain

    • Tso-Ta Huang, Taiwan

      Tso-Ta Huang, Taiwan

    • Andres Estevez Guersznik, Ireland

      Andres Estevez Guersznik, Ireland

    • Alex, Argentina

      Alex, Argentina

    • Wilfried Leusing, Germany

      Wilfried Leusing, Germany

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login